K223249 is an FDA 510(k) clearance for the Pro-Tx Endorectal Balloon (PROT-25). Classified as Prostate Immobilizer Rectal Balloon (product code PCT), Class II - Special Controls.
Submitted by Dxtx Medical, Inc. (Pittsburgh, US). The FDA issued a Cleared decision on February 10, 2023 after a review of 151 days - an extended review cycle.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5720 - the FDA radiology and imaging software oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.
Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.
View all Dxtx Medical, Inc. devices